(Video) VCS Interview with Dr. Andrew Novosad

Dr. Sue Cancer Vet posted an oncologist interview with Dr. Andrew Novosad as part of her VCS interview series. Novosad described TANOVEA-CA1 (rabacfosadine for injection) as the most significant highlight of this year’s VCS Conference and shared why he is so … Keep Reading

VetDC Announces New TANOVEA®-CA1 Publication, State of the Art Presentation at VCS 2017 Annual Conference

FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., the leading veterinary cancer therapeutics company, today announced a new TANOVEA®-CA1 (rabacfosadine for injection) publication in Veterinary & Comparative Oncology.  Data from this publication and several new VetDC-sponsored studies was prominently featured in a State … Keep Reading